TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PharMedCon Europe AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
520
|
1,368
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
295
|
1,075
|
-17 |
| EBITDA |
280
|
1,066
|
-17 |
| Total assets |
2,295
|
2,157
|
1,169 |
| Current assets |
540
|
747
|
17 |
| Current liabilities |
40
|
81
|
7 |
| Equity capital |
2,160
|
1,996
|
1,141 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
94.1%
|
92.5%
|
97.6% |
| Turnover per employee |
520
|
1,368 | |
| Profit as a percentage of turnover |
56.7%
|
78.6% | |
| Return on assets (ROA) |
12.9%
|
49.8%
|
-1.5% |
| Current ratio |
1350.0%
|
922.2%
|
242.9% |
| Return on equity (ROE) |
13.7%
|
53.9%
|
-1.5% |
| Change turnover |
-803
|
1,368
|
0 |
| Change turnover % | -61% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.